You are here

Gender and the Genome

Gender and the Genome

Published in Association with The Foundation for Gender-Specific Medicine

Editor
Marianne J. Legato, MD, PhD Columbia University College of Physicians & Surgeons, New York, NY, USA


eISSN: 24702900 | ISSN: 24702897 | Current volume: 2 | Current issue: 4

Gender and the Genome is a peer-reviewed open access journal that explores how the new science of the 21st century is profoundly influenced by biological sex. Through evidence-based original research, reviews, perspectives, and commentaries, the Journal illuminates the impact of biological sex on technology and its effects on human life. The Journal’s international editorial board is comprised of the most forward-thinking leaders in gender-specific medicine to engage the community of molecular biologists, engineers, ethicists, anthropologists, and legal experts in a dialogue about the nature and implications of 21st century technology.

Gender and the Genome coverage includes:

  • Sex-specific differences in genomic, cellular, tissue, and whole animal function
  • New life forms generated by synthetic biology
  • Technological advances meant to enhance the function in humans, whether compromised by disease/injury or in normal individuals
  • Manufacture and usefulness of robotic devices
  • Commentaries by ethicists, theologians, anthropologists, epidemiologists, and sociologists/social scientists on the achievements of 21st century science to alter the genome, create new life forms, and develop technologically enhanced humans

Gender and the Genome is under the editorial leadership of Editor-in-Chief Marianne J. Legato, MD, PhD (hon. c.), FACP, Emerita Professor of Clinical Medicine, Columbia University; Adjunct Professor of Medicine, Johns Hopkins School of Medicine; and Founder, Foundation for Gender-Specific Medicine; and other leading investigators.

Gender and the Genome is the Official Journal of The Foundation for Gender-Specific Medicine.  


Open access article processing charge (APC) information

The APC for this journal is currently 750 USD.

The article processing charge (APC) is payable when a manuscript is accepted after peer review, before it is published. The APC is subject to taxes where applicable. Tax-exempt status can be indicated by providing appropriate registration numbers when payment is requested. Please see further details here.


Submit your manuscript today at http://mc.manuscriptcentral.com/gng


Contact

Please direct any enquiries to kiley.allen@sagepub.com

Gender and the Genome is a peer reviewed, open access journal that explores how the new science of the 21st century is profoundly influenced by biological sex. Through evidence-based original research, reviews, perspectives, and commentaries, the Journal illuminates the impact of biological sex on technology and its effects on human life.

Audience: Molecular biologists, epidemiologists, immunologists, engineers, ethicists, anthropologists, sociologists/social scientists, and legal experts, among others.

Editor in Chief
Marianne J. Legato, MD, PhD Columbia University College of Physicians & Surgeons, New York, NY, USA
Steering Committee
Marek Glezerman, MD Sackler Medical School, Tel Aviv University, Tel Aviv, Israel
Marjorie R. Jenkins, MD, MEHP, FACP Texas Tech University Health Sciences Center, Food and Drug Administration, Silver Spring, MD, USA
Justin P. Killian, Esq. The Foundation for Gender-Specific Medicine, New York, NY, USA
Marianne J. Legato, MD, PhD Columbia University College of Physicians & Surgeons, New York, NY, USA
Alyson J. McGregor, MD, MA, FACEP Warren Alpert Medical School, Brown University, Providence, RI, USA
Virginia M. Miller, PhD Mayo Clinic, Rochester, MN
Jane F. Reckelhoff, PhD University of Mississippi Medical Center, Jackson, MS, USA
Associate Editors
Marek Glezerman, MD Sackler Medical School, Tel Aviv University, Tel Aviv, Israel
Editorial Board
Fernando Abad-Franch, MD, PhD Centro de Pesquisa René Rachou - Fiocruz, Belo Horizonte, Brazil
Thurayya Arayssi, MD, FACP, FACR, FRCP Weill Cornell Medicine - Qatar, Doha, Qatar
Arthur P. Arnold, PhD University of California, Los Angeles, Los Angeles, CA, USA
Hrayr P. Attarian, MD, FACCP, FAASM Northwestern University Feinberg School of Medicine, Chicago, IL, USA
Giovannella Baggio, MD University of Padua, Padua, Italy
Neil A. Bradbury, PhD Chicago Medical School, Chicago, IL, USA
Eliza Chin, MD, MPH American Medical Women's Association, Reston, VA, USA
Aaron Ciechanover, MD, DSc The Technion Institute, Israel
Terri L. Cornelison, MD, PhD, FACOG U.S. Food and Drug Administration, Silver Spring, Maryland, USA
Gayatri Devi, MD, FAAN, FACP State University of New York at Downstate, New York, NY, USA
Adrian S. Dobs, MD, MHS The Johns Hopkins University School of Medicine, Baltimore, MD, USA
Gillian Einstein, PhD University of Toronto, Toronto, ON, Canada
Dov Feldberg, MD Sackler Medical School, Tel Aviv University, Tel Aviv, Israel
Camilo Fernandez, MD, MSc, MBA, MCTS, FASH, FASE H.L. Brighton Center for Advanced Cardiovascular Diagnostics, Brighton, MA, USA
Robert C. Froemke, PhD New York University School of Medicine, New York, NY, USA
Marek Glezerman, MD Sackler Medical School, Tel Aviv University, Tel Aviv, Israel
Marjorie R. Jenkins, MD, MEHP, FACP Texas Tech University Health Sciences Center, Food and Drug Administration, Silver Spring, MD, USA
Paula A. Johnson, MD, MPH Wellesley College, Wellesley, MA
Alexandra Kautzky-Willer, MD Medical University Vienna, Vienna, Austria
Jasna Markovac, PhD California Institute of Technology, Pasadena, CA, USA
Alyson J. McGregor, MD, MA, FACEP Warren Alpert Medical School, Brown University, Providence, RI, USA
Virginia M. Miller, PhD Mayo Clinic, Rochester, MN
Maria Grazia Modena Universitá Di Modena E Reggio Emilia, Modena, Italy
Padmaja Mummaneni, PhD Regulatory Scientist, Bethesda, MD
Pamela Ouyang, MBBS, MD The Johns Hopkins University School of Medicine, Baltimore, MD
Ingrid Perscky, MD Global Men's Health Foundation, Panama City, Panama
Vivian W. Pinn, MD Fogarty International Center at NIH, Bethesda, MD, USA
Jane F. Reckelhoff, PhD University of Mississippi Medical Center, Jackson, MS, USA
Vera Regitz-Zagrosek, MD, PhD Charité - Universitätsmedizin Berlin, Berlin, Germany
Basmah Safdar, MD, MSc Yale University School of Medicine, New Haven, CT, USA
Ibis Sánchez-Serrano, MALD, BSc The Core Model Corporation, S.A., Panama City, Panama
Karin Schenck-Gustafsson, MD, PhD, FESC Karolinska Institutet and Karolinska University Hospital, Stockholm, Sweden
Hiroaki Shimokawa, MD, PhD Tohoku University Graduate School of Medicine, Sendai, Japan
Francoise L. Simon, PhD Mount Sinai School of Medicine, Columbia University, New York, NY, USA
Jeanette Strametz-Juranek, MD Medical University of Vienna, Vienna, Austria
Kimberly J. Templeton, MD University of Kansas Medical Center, Kansas City, KS, USA
Janice Werbinski, MD Western Michigan University Homer Stryker School of Medicine, Kalamazoo, MI, USA
  • Directory of Open Access Journals (DOAJ)
  • This Journal recommends that authors follow the Recommendations for the Conduct, Reporting, Editing, and Publication of Scholarly Work in Medical Journals formulated by the International Committee of Medical Journal Editors (ICMJE).

    Please read the guidelines below then visit the journal’s submission site to upload your manuscript. Please note that manuscripts not conforming to these guidelines may be returned.

    Only manuscripts of sufficient quality that meet the aims and scope of Gender and the Genome will be reviewed.

    As part of the submission process you will be required to warrant that you are submitting your original work, that you have the rights in the work, that you are submitting the work for first publication in the Journal and that it is not being considered for publication elsewhere and has not already been published elsewhere, and that you have obtained and can supply all necessary permissions for the reproduction of any copyright works not owned by you.

    Please Read the Manuscript Submission Guidelines below before submitting your manuscript here:
    SUBMIT MANUSCRIPT

    1. Open Access
    2. Article processing charge (APC)
    3. What do we publish?
      3.1 Aims & scope
      3.2 Article types
      3.3 Writing your paper
      3.3.1 Making your article discoverable 
    4. Editorial policies
      4.1 Peer Review Policy
      4.2 Authorship
      4.3 Acknowledgements
      4.4 Funding
      4.5 Declaration of conflicting interests
      4.6 Research ethics and patient consent
      4.7 Clinical Trials
      4.8 Reporting guidelines
      4.9 Research Data
    5. Publishing policies
      5.1 Publication ethics
      5.2 Contributor's publishing agreement
    6. Preparing your manuscript
      6.1 Word processing formats
      6.2 Artwork, figures and other graphics
      6.3 Supplemental material
      6.4 Reference style
      6.5 English language editing services
    7. Submitting your manuscript
      7.1 How to submit your manuscript
      7.2 Title, keywords and abstracts
      7.3 Information required for completing your submission
      7.4 ORCID
      7.5 Information required for completing your submission
      7.6 Permissions
    8. On acceptance and publication
      8.1 SAGE Production
      8.2 Continuous publication
      8.3 Promoting your article
    9. Further information

    1. Open Access

    Gender and the Genome is an open access, peer-reviewed journal. Each article
    accepted by peer review is made freely available online immediately upon publication, is published
    under a Creative Commons license and will be hosted online in perpetuity. Publication costs of the
    journal are covered by the collection of article processing charges which are paid by the funder,
    institution or author of each manuscript upon acceptance. There is no charge for submitting a paper to
    the journal.

    For general information on open access at SAGE please visit the Open Access page or view our Open
    Access FAQs
    .

    Back to top

    2. Article processing charge (APC)

    If, after peer review, your manuscript is accepted for publication, a one-time article processing charge
    (APC) is payable. This APC covers the cost of publication and ensures that your article will be freely
    available online in perpetuity under a Creative Commons license.

    An article processing charge (APC) of 750 USD is payable upon acceptance. 

    *The article processing charge (APC) is payable upon acceptance after peer review and is subject to value
    added tax (VAT) where applicable. If the paying author/institution is based in the European Union, to
    comply with European law, VAT must be added to the APC. Providing a VAT registration number will
    allow an institution to avoid paying this tax, except for UK institutions. Payments can be made in GBP or
    USD.

    Back to top

    3. What do we publish?

    3.1 Aims & scope

    Before submitting your manuscript to Gender and the Genome, please ensure you have read the Aims &
    Scope. 

    3.2 Article types

    Word limits do not include the title, abstract, figure legends, references,
    acknowledgments, or disclosure statements.

    • Original Articles: 3500 words
    • Review Articles: 8,000 words
    • Brief Communications: 1,500 words
    • Commentaries: 1,000 words
    • Letter to the Editor: 500 words

    Title Page (Required).

    The title page of your submission, and the abstract, must be included as part of
    your main text document
    (not as separate files). The title page must include the
    following items:

    • The complete title of the article (title should not exceed 15-18 words)
    • All contributing authors’ full names, complete affiliation and mailing address,
      and valid email addresses
    • A brief running title (no more than 50 characters, including spaces)
    • The corresponding author’s complete contact information including
      postal address and current e-mail address.
    • A minimum of four keywords to assist in the peer-review process.

    Abstract. For all original and review papers, the next page of the manuscript should consist of
    a non-structured abstract of no more than 400 words, which should be self-explanatory without
    reference to the text. References, proprietary, and trade names are not permitted in the abstract.

    Keywords. Please provide a minimum of four keywords below the abstract.

    Text. The text of the manuscript should follow this format:
    Abstract
    Introduction
    Materials and Methods
    Results
    Discussion
    Conclusion
    Acknowledgments
    Author Disclosure Statement
    References

    All manuscripts should be double-spaced.
    For all material sources, such as devices, drugs, etc., indicate manufacturer/supplier name,
    city, state, and country.

    Footnotes. Use of footnotes is discouraged. If footnotes are necessary, prepare footnotes
    double-spaced on a separate page within the main text file of your submission.

    Acknowledgments. Collaborations, sources of research funds, and other acknowledgments
    should be listed in a separate section at the end of the text ahead of the References section.

    Author Disclosure Statement. Immediately following the Acknowledgments section, include a
    header entitled, “Author Disclosure Statement.” All authors are expected to disclose any
    institutional or commercial affiliations that might pose a conflict of interest regarding the
    publication of a manuscript. Institutional affiliations, as indicated on the title page, should include
    all corporate affiliations and any funding sources that support the work. Other types of affiliation,
    including consultancies, honoraria, stock ownership, equity interests, arrangements regarding
    patents, or other vested interests should also be disclosed in the Disclosure sect

    3.3 Writing your paper

    The SAGE Author Gateway has some general advice and on how to get published, plus links to further
    resources

    3.3.1 Making your article discoverable 

    When writing up your paper, think about how you can make it discoverable. The title, keywords and abstract
    are key to ensuring readers find your article through search engines such as Google. For information and
    guidance on how best to title your article, write your abstract and select your keywords, have a look at this
    page on the Gateway: How to Help Readers Find Your Article Online

    Back to top

    4. Editorial policies

    4.1 Peer review policy

    Gender and the Genome utilizes a single-blind peer review process in which the reviewer’s name
    and information is withheld from the author.

    FOR JOURNALS USING RECOMMENDED/OPPOSED REVIEWERS
    As part of the submission process you will be asked to provide the names of [3-4] peers who could be called
    upon to review your manuscript. Recommended reviewers should be experts in their fields and should be able
    to provide an objective assessment of the manuscript. Please be aware of any conflicts of interest when
    recommending reviewers. Examples of conflicts of interest include (but are not limited to) the below:

    • The reviewer should have no prior knowledge of your submission
    • The reviewer should not have recently collaborated with any of the authors
    • Reviewer nominees from the same institution as any of the authors are not permitted

    You will also be asked to nominate peers who you do not wish to review your manuscript (opposed reviewers).
    Please note that the Editors are not obliged to invite/reject any recommended/opposed reviewers to assess
    your manuscript.

    FOR JOURNALS INTEGRATED WITH PUBLONS
    Gender and the Genome is committed to delivering high quality, fast peer-review for your paper, and as such
    has partnered with Publons. Publons is a third party service that seeks to track, verify and give credit for peer
    review. Reviewers for [Journal] can opt in to Publons in order to claim their reviews or have them
    automatically verified and added to their reviewer profile. Reviewers claiming credit for their review will be
    associated with the relevant journal, but the article name, reviewer’s decision and the content of their review
    is not published on the site. For more information visit the Publons website.

    The Editor or members of the Editorial Board may occasionally submit their own manuscripts for possible
    publication in the journal. In these cases, the peer review process will be managed by alternative members of
    the Board and the submitting Editor/Board member will have no involvement in the decision-making process.

    4.2 Authorship

    Papers should only be submitted for consideration once consent is given by all contributing authors. Those
    submitting papers should carefully check that all those whose work contributed to the paper are
    acknowledged as contributing authors.
    The list of authors should include all those who can legitimately claim authorship. This is all those who:

    (i) Made a substantial contribution to the concept or design of the work; or acquisition, analysis
    or interpretation of data,
    (ii) Drafted the article or revised it critically for important intellectual content,
    (iii) Approved the version to be published,
    (iv) Each author should have participated sufficiently in the work to take public responsibility for
    appropriate portions of the content.

    Authors should meet the conditions of all of the points above. When a large, multicentre group has conducted
    the work, the group should identify the individuals who accept direct responsibility for the manuscript. These
    individuals should fully meet the criteria for authorship.

    Acquisition of funding, collection of data, or general supervision of the research group alone does not
    constitute authorship, although all contributors who do not meet the criteria for authorship should be listed in
    the Acknowledgments section. Please refer to the International Committee of Medical Journal Editors (ICMJE)
    authorship guidelines
    for more information on authorship.

    4.3 Acknowledgements

    All contributors who do not meet the criteria for authorship should be listed in an Acknowledgements section.
    Examples of those who might be acknowledged include a person who provided purely technical help, or a
    department chair who provided only general support.

    Any acknowledgements should appear first at the end of your article prior to your Declaration of Conflicting
    Interests (if applicable), any notes and your References.

    4.3.1 Writing assistance

    Individuals who provided writing assistance, e.g. from a specialist communications company, do not qualify as
    authors and so should be included in the Acknowledgements section. Authors must disclose any writing
    assistance – including the individual’s name, company and level of input – and identify the entity that paid for
    this assistance. It is not necessary to disclose use of language polishing services.

    4.4 Funding

    Gender and the Genome requires all authors to acknowledge their funding in a consistent fashion under a
    separate heading. Please visit the Funding Acknowledgements page on the SAGE Journal Author Gateway to
    confirm the format of the acknowledgment text in the event of funding, or state that: This research received
    no specific grant from any funding agency in the public, commercial, or not-for-profit sectors

    4.5 Declaration of conflicting interests

    It is the policy of Gender and the Genome to require a declaration of conflicting interests from all authors
    enabling a statement to be carried within the paginated pages of all published articles.
    Please ensure that a ‘Declaration of Conflicting Interests’ statement is included at the end of your manuscript,
    after any acknowledgements and prior to the references. If no conflict exists, please state that ‘The Author(s)
    declare(s) that there is no conflict of interest’. For guidance on conflict of interest statements, please see the
    ICMJE recommendations here.

    4.6 Research ethics and patient consent

    Medical research involving human subjects must be conducted according to the World Medical Association
    Declaration of Helsinki

    Submitted manuscripts should conform to the ICMJE Recommendations for the Conduct, Reporting, Editing,
    and Publication of Scholarly Work in Medical Journals
    , and all papers reporting animal and/or human studies
    must state in the methods section that the relevant Ethics Committee or Institutional Review Board provided
    (or waived) approval. Please ensure that you have provided the full name and institution of the review
    committee, in addition to the approval number.

    For research articles, authors are also required to state in the methods section whether participants provided
    informed consent and whether the consent was written or verbal.

    Information on informed consent to report individual cases or case series should be included in the manuscript
    text. A statement is required regarding whether written informed consent for patient information and images to
    be published was provided by the patient(s) or a legally authorized representative. Please do not submit the
    patient’s actual written informed consent with your article, as this in itself breaches the patient’s confidentiality.
    The Journal requests that you confirm to us, in writing, that you have obtained written informed consent but the
    written consent itself should be held by the authors/investigators themselves, for example in a patient’s hospital
    record. The confirmatory letter may be uploaded with your submission as a separate file.

    Please also refer to the ICMJE Recommendations for the Protection of Research Participants

    All research involving animals submitted for publication must be approved by an ethics committee with
    oversight of the facility in which the studies were conducted. The journal has adopted the Consensus Author
    Guidelines on Animal Ethics and Welfare for Veterinary Journals
    published by the International Association of
    Veterinary Editors. 

    4.7 Clinical trials

    Gender and the Genome conforms to the ICMJE requirement that clinical trials are registered in a WHOapproved
    public trials registry at or before the time of first patient enrolment as a condition of consideration
    for publication. The trial registry name and URL, and registration number must be included at the end of the
    abstract.

    Gender and the Genome endorses the ICMJE requirement that clinical trials are registered in a WHO-approved
    public trials registry at or before the time of first patient enrolment. However, consistent with the AllTrials
    campaign
    , retrospectively registered trials will be considered if the justification for late registration is
    acceptable.

    4.8 Reporting guidelines

    The relevant EQUATOR Network reporting guidelines should be followed depending on the type of study. For
    example, all randomized controlled trials submitted for publication should include a completed CONSORT flow
    chart as a cited figure and the completed CONSORT checklist should be uploaded with your submission as a
    supplementary file. Systematic reviews and meta-analyses should include the completed PRISMA flow chart as
    a cited figure and the completed PRISMA checklist should be uploaded with your submission as a
    supplementary file. The EQUATOR wizard can help you identify the appropriate guideline.

    Other resources can be found at NLM’s Research Reporting Guidelines and Initiatives

    4.9 Research Data

    At SAGE we are committed to facilitating openness, transparency and reproducibility of research. Where relevant, Gender and the Genome encourages authors to share their research data in a suitable public repository subject to ethical considerations and to include a data accessibility statement in their manuscript file. Authors should also follow data citation principles. For more information please visit the SAGE Author Gateway, which includes information about SAGE’s partnership with the data repository Figshare. 

    Back to top

    5. Publishing policies

    5.1 Publication ethics

    SAGE is committed to upholding the integrity of the academic record. We encourage authors to refer to the
    Committee on Publication Ethics’ International Standards for Authors and view the Publication Ethics page on
    the SAGE Author Gateway

    5.1.1 Plagiarism

    Gender and the Genome and SAGE take issues of copyright infringement, plagiarism or other breaches of best
    practice in publication very seriously. We seek to protect the rights of our authors and we always investigate
    claims of plagiarism or misuse of published articles. Equally, we seek to protect the reputation of the journal
    against malpractice. Submitted articles may be checked with duplication-checking software. Where an article,
    for example, is found to have plagiarised other work or included third-party copyright material without
    permission or with insufficient acknowledgement, or where the authorship of the article is contested, we
    reserve the right to take action including, but not limited to: publishing an erratum or corrigendum
    (correction); retracting the article; taking up the matter with the head of department or dean of the author's
    institution and/or relevant academic bodies or societies; or taking appropriate legal action.

           5.2 Contributor's publishing agreement

           Before publication SAGE requires the author as the rights holder to sign a Journal Contributor’s
           Publishing Agreement. GNG publishes manuscripts under Creative Commons licenses. The
           standard license for the journal is Creative Commons by Attribution Non-Commercial (CC BYNC),
           which allows others to re-use the work without permission as long as the work is properly
           referenced and the use is non-commercial. For more information, you are advised to visit
           SAGE's OA licenses page.

           Alternative license arrangements are available, for example, to meet particular funder
           mandates, made at the author’s request. 

    Back to top

    6. Preparing your manuscript

    6.1 Word processing formats

    For the main text document, upload in Microsoft Word format. If you have a PDF copy to upload, please ensure
    that you also upload the Word version. Word templates are available on the Manuscript Submission Guidelines
    page of our Author Gateway.

    6.2 Artwork, figures and other graphics

    Tables: Prepare tables double-spaced, one to a page and placed after the Reference section. Each table must
    stand alone, i.e., contain all necessary information in the table title and be understood independently of the
    text. Avoid repetition of information that is given in the text. Supply a title for each table. 

    Figures and Legends: Figures must be submitted separately using the following guidelines: Do NOT include any
    type of illustrations as part of your text file. Do NOT prepare any figures in Word, as they are not workable.
    Name figure files using only alphanumeric characters. Do not use spaces, symbols, dots, or dashes. File names
    should be formatted with the first author's name and figure number (Ex: SmithFig1). Lin illustrations must be
    submitted at 900 DPI. Halftimes and color photos should be submitted at a minimum of 300 DPI. Save figures
    as either TIFF or EPS files. Color figures must be saved as CYMK, not RGB. Do not include the legend in the
    figure file. Figure legends must be prepared as an enumerated list as a separate file.

    Figures supplied in colour will appear in colour online. There is no charge for reproducing figures in colour in
    the printed version. 

    6.3 Supplemental material

    This journal is able to host additional materials online (e.g. datasets, podcasts, videos, images etc.) alongside
    the full-text of the article. For more information please refer to our guidelines on submitting supplementary
    files
    .

    6.4 Reference style

    Gender and the Genome adheres to the AMA reference style. View the AMA guidelines to ensure your
    manuscript conforms to this reference style. 

    6.5 English language editing services

    Authors seeking assistance with English language editing, translation, or figure and manuscript formatting to fit
    the journal’s specifications should consider using SAGE Language Services. Visit SAGE Language Services on our
    Journal Author Gateway for further information.

    Back to top

    7. Submitting your manuscript

    7.1 How to submit your manuscript

    To submit your manuscript to Gender and the Genome, please visit our manuscript
    submission site
    . Please ensure that references are formatted with the AMA reference style. 

    IMPORTANT: Please check whether you already have an account in the system before trying to create a new
    one. If you have reviewed or authored for the journal in the past year it is likely that you will have had an
    account created. For further guidance on submitting your manuscript online please visit ScholarOne Online
    Help.

    7.2 Title, keywords and abstracts

    Please supply a title, short title, an abstract and keywords to accompany your article. The title,
    keywords and abstract are key to ensuring readers find your article online through online search
    engines such as Google. Please refer to the information and guidance on how best to title your
    article, write your abstract and select your keywords by visiting the SAGE Journal Author
    Gateway for guidelines on How to Help Readers Find Your Article Online

    7.3 Information required for completing your submission

    Provide full contact details for the corresponding author including email, mailing address and
    telephone numbers. Academic affiliations are required for all co-authors. These details should
    be presented separately to the main text of the article to facilitate anonymous peer review.

    You will be asked to provide contact details and academic affiliations for all co-authors via the
    submission system and identify who is to be the corresponding author. These details must
    match what appears on your manuscript. At this stage please ensure you have included all the
    required statements and declarations and uploaded any additional supplementary files
    (including reporting guidelines where relevant).

    7.4 ORCID

    As part of our commitment to ensuring an ethical, transparent and fair peer review process SAGE
    is a supporting member of ORCID, the Open Researcher and Contributor ID. ORCID provides a
    unique and persistent digital identifier that distinguishes researchers from every other researcher,
    even those who share the same name, and, through integration in key research workflows such
    as manuscript and grant submission, supports automated linkages between researchers and their
    professional activities, ensuring that their work is recognized. 

    The collection of ORCID IDs from corresponding authors is now part of the submission process of
    this journal. If you already have an ORCID iD you will be asked to associate that to your
    submission during the online submission process. We also strongly encourage all co-authors to
    link their ORCID ID to their accounts in our online peer review platforms. It takes seconds to do:
    click the link when prompted, sign into your ORCID account and our systems are automatically
    updated. Your ORCID iD will become part of your accepted publication’s metadata, making your
    work attributable to you and only you. Your ORCID iD is published with your article so that fellow
    researchers reading your work can link to your ORCID profile and from there link to your other
    publications.

    If you do not already have an ORCID ID please follow this link to create one or visit our ORCID
    homepage
    to learn more.

    7.5 Information required for completing your submission

    You will be asked to provide contact details and academic affiliations for all co-authors via the
    submission system and identify who is to be the corresponding author. These details must match
    what appears on your manuscript. The affiliation listed on the manuscript should be the institution
    where the research was conducted. If an author has moved to a new institution since completing
    the research, the new affiliation can be included in a manuscript note at the end of the paper. At
    this stage please ensure you have included all the required statements and declarations and
    uploaded any additional supplementary files (including reporting guidelines where relevant).

    7.6 Permissions

    Please ensure that you have obtained any necessary permission from copyright holders for
    reproducing any illustrations, tables, figures or lengthy quotations previously published elsewhere.
    For further information including guidance on fair dealing for criticism and review, please see the
    Copyright and Permissions page on the SAGE Journal Author Gateway. 

    Back to top

    8. On acceptance and publication

    [Insert text here]

    8.1 SAGE Production

    Your SAGE Production Editor will keep you informed as to your article’s progress throughout the
    production process. Proofs will made available to the corresponding author via our editing portal
    SAGE Edit, or by email to the corresponding author and should be returned promptly.  Authors are
    reminded to check their proofs carefully to confirm that all author information, including names,
    affiliations, sequence and contact details are correct, and that Funding and Conflict of Interest
    statements, if any, are accurate. Please note that if there are any changes to the author list at this
    stage all authors will be required to complete and sign a form authorizing the change.

    8.2 Online publication

    Online First allows final articles (completed and approved articles awaiting assignment to a future issue) to be
    published online prior to their inclusion in a journal issue, which significantly reduces the lead time between
    submission and publication. Visit the SAGE Journals help page for more details, including how to cite Online
    First articles.

    8.3 Promoting your article

    Publication is not the end of the process! You can help disseminate your paper and ensure it is as widely read
    and cited as possible. The SAGE Author Gateway has numerous resources to help you promote your work. Visit
    the Promote Your Article page on the Gateway for tips and advice. In addition, SAGE is partnered with Kudos, a
    free service that allows authors to explain, enrich, share, and measure the impact of their article. Find out how
    to maximise your article’s impact with Kudos. 

    Back to top

    9. Further information

    Any correspondence, queries or additional requests for information on the manuscript submission process
    should be sent to the Gender and the Genome editorial office as follows:

    Wendy Dauber
    Email: wdauber@gendermed.org
    Tel: 212-737-5663
    Fax: 212-737-6306 

    Back to top